MetaADEDB 2.0 @ LMMD
Praziquantel
(FSVJFNAIGNNGKK-UHFFFAOYSA-N)
Structure
SMILES
O=C(N1CC(=O)N2C(C1)c1ccccc1CC2)C1CCCCC1
Type(s)
Approved; Investigational; Vet_approved
ATC code(s)
P02BA01
Molecular Formula:
C19H24N2O2
Molecular Weight:
312.406
Log P:
2.4107
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
40.62
CAS Number(s):
55268-74-1; 135526-78-2
Synonym(s)
1.
Praziquantel
2.
Biltricide
3.
Cesol
4.
Cisticid
5.
Cysticide
6.
Droncit
7.
Drontsit
8.
EMBAY 8440
9.
Prasiquantel
10.
Praziquantel, (+-)-Isomer
11.
Praziquantel, (R)-Isomer
12.
Praziquantel, (S)-Isomer
13.
Pyquiton
14.
Traziquantel
External Link(s)
MeSHD011223
PubChem Compound4891
BindingDB74574
ChEBI91583
CHEMBLCHEMBL976
DrugBankDB01058
DrugCentral2241
KEGGcpd:C07367
dr:D00471
Therapeutic Target DatabaseD0L9ZR
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1SchistosomiasisFAERS: 83897559CTD
US FAERS
2Drug ineffectiveFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
3MalaiseFAERS: 6SIDER
US FAERS
4UrticariaFAERS: 6SIDER
US FAERS
5DizzinessFAERS: 5
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
6EosinophiliaFAERS: 4SIDER
US FAERS
7Red blood cell schistocytes presentFAERS: 4US FAERS
8Abdominal PainFAERS: 3

View details

CTD
SIDER
US FAERS
9Cerebral InfarctionFAERS: 33407004CTD
US FAERS
10FatigueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
11No adverse eventFAERS: 3US FAERS
12Portal HypertensionFAERS: 3US FAERS
13Product use in unapproved indicationFAERS: 3US FAERS
14PruritusFAERS: 3
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
15Anaphylactic shockFAERS: 2US FAERS
16AngioedemaFAERS: 2US FAERS
17AnosognosiaFAERS: 2US FAERS
18AscitesFAERS: 2US FAERS
19Chest PainFAERS: 2US FAERS
20ConstipationFAERS: 2US FAERS
21General physical health deteriorationFAERS: 2US FAERS
22HeadacheFAERS: 2
Canada Vigilance: 2

View details

CTD
SIDER
Canada Vigilance
US FAERS
23HypersensitivityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
24Inappropriate schedule of drug administrationFAERS: 2US FAERS
25Mental impairmentFAERS: 2US FAERS
26NauseaFAERS: 2
Canada Vigilance: 2

View details

CTD
SIDER
Canada Vigilance
US FAERS
27Neurological decompensationFAERS: 2US FAERS
28PainFAERS: 27330947CTD
US FAERS
29Portal Vein ThrombosisFAERS: 2US FAERS
30Portal fibrosisFAERS: 2US FAERS
31SplenomegalyFAERS: 2US FAERS
32SyncopeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
33Abdominal tendernessFAERS: 1US FAERS
34Acute respiratory failureFAERS: 1US FAERS
35Adverse eventFAERS: 1US FAERS
36Application site dischargeFAERS: 1US FAERS
37Arthropod biteFAERS: 1US FAERS
38AstheniaFAERS: 1SIDER
US FAERS
39BedriddenFAERS: 1US FAERS
40BronchospasmFAERS: 1US FAERS
41Chest discomfortFAERS: 1US FAERS
42CholestasisFAERS: 1US FAERS
43ChromaturiaFAERS: 1US FAERS
44Conversion disorderFAERS: 1US FAERS
45CryingFAERS: 1US FAERS
46CystFAERS: 1US FAERS
47Cytolytic hepatitisFAERS: 1US FAERS
48DeliriumFAERS: 1US FAERS
49Disease recurrenceFAERS: 1US FAERS
50Dry skinFAERS: 1US FAERS
51ErythemaFAERS: 1US FAERS
52Escherichia infectionFAERS: 1US FAERS
53Eyelash thickeningFAERS: 1US FAERS
54Feeling abnormalFAERS: 1SIDER
US FAERS
55FormicationFAERS: 1US FAERS
56HepatomegalyFAERS: 1US FAERS
57HepatosplenomegalyFAERS: 1US FAERS
58HymenolepiasisFAERS: 13054764CTD
US FAERS
59HypotensionFAERS: 1US FAERS
60IncoherentFAERS: 1US FAERS
61Increased viscosity of bronchial secretionFAERS: 1US FAERS
62Intention tremorFAERS: 1US FAERS
63Livedo ReticularisFAERS: 1US FAERS
64Lyme DiseaseFAERS: 1US FAERS
65LymphadenopathyFAERS: 1US FAERS
66Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
67Nasal discomfortFAERS: 1US FAERS
68Nasal inflammationFAERS: 1US FAERS
69Oral dischargeFAERS: 1US FAERS
70Oropharyngeal discomfortFAERS: 1US FAERS
71Oropharyngeal painFAERS: 1US FAERS
72PalpitationsFAERS: 1US FAERS
73PancytopeniaFAERS: 1US FAERS
74Pathogen resistanceFAERS: 1US FAERS
75PlagueFAERS: 1US FAERS
76PolyserositisFAERS: 1SIDER
US FAERS
77Product quality issueFAERS: 1US FAERS
78Product use issueFAERS: 1US FAERS
79PterygiumFAERS: 1US FAERS
80Respiratory FailureFAERS: 1US FAERS
81Respiratory distressFAERS: 1US FAERS
82Salmonella test positiveFAERS: 1US FAERS
83ScabFAERS: 1US FAERS
84Skin lesionFAERS: 1US FAERS
85Superficial vein prominenceFAERS: 1US FAERS
86ThrombocytopeniaFAERS: 1US FAERS
87TremorFAERS: 1US FAERS
88Vaginal DischargeFAERS: 1US FAERS
89Visual disturbanceFAERS: 1US FAERS
90VomitingFAERS: 1
Canada Vigilance: 1
3897559
7330947
CTD
SIDER
Canada Vigilance
US FAERS
91Vulvovaginal pruritusFAERS: 1US FAERS
92WheezingFAERS: 1US FAERS
93Abdominal discomfortSIDER
94AnorexiaSIDER
95ArthralgiaCanada Vigilance: 1Canada Vigilance
96Atrioventricular BlockSIDER
97BradycardiaSIDER
98Cardiovascular Diseases6673126CTD
99Cestode Infections17184919
17695802
21234239
CTD
100Chemical and Drug Induced Liver Injury6673126CTD
101Cysticercosis9886213CTD
102DermatitisSIDER
103Diarrhea3054764
3897559
CTD
104Diphyllobothriasis7330947CTD
105Dirofilariasis25936435CTD
106DiscomfortSIDER
107Dog Diseases17184919
18661153
19575233
CTD
108DrowsinessSIDER
109Gastritis7330947CTD
110Gastrointestinal PainSIDER
111Giardiasis18661153
19575233
CTD
112Helminthiasis12886816CTD
113Intestinal Diseases, Parasitic17695802CTD
114Intracranial Hypertension11565520CTD
115Liver Cirrhosis, Experimental24818384CTD
116Liver Cirrhosis18473419CTD
117Mental disorders6673126CTD
118MyalgiaSIDER
119Nematode infections17184919
21234239
CTD
120Neurocysticercosis

View details

CTD
121Opisthorchiasis8896890
21256849
CTD
122Paresthesia7330947CTD
123Schistosomiasis japonica6673126
24818384
CTD
124Schistosomiasis mansoni8898462
29054683
CTD
125Seizures

View details

CTD
126SomnolenceSIDER
127Tachycardia7330947CTD
128Trematode Infections21234239CTD
129Ventricular FibrillationSIDER
130VertigoSIDER
131nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.